Theriva Biologics

TOVX

----

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Theriva Biologics(TOVX) predict that the Revenue is 300 K (--%), Beat estimate;the EBIT is -2.127 M (+51.85%), Beat estimate;the EPS is -0.05 (+96.77%), Meet estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.00B--

+0.00B--%

EBITExceed expectations

-0.00B51.85%

-0.00B47.88%

+0.00B3.97%

EPS

-0.0596.77%

0.00000.00%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD